343 related articles for article (PubMed ID: 17878795)
1. Legg-Calve-Perthes disease, venous and arterial thrombi, and the factor V Leiden mutation in a four-generation kindred.
Glueck CJ; Tracy T; Wang P
J Pediatr Orthop; 2007; 27(7):834-7. PubMed ID: 17878795
[TBL] [Abstract][Full Text] [Related]
2. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
Glueck CJ; Wang P
Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
[TBL] [Abstract][Full Text] [Related]
3. Inherited risk factors for thrombophilia among children with Legg-Calvé-Perthes disease.
Arruda VR; Belangero WD; Ozelo MC; Oliveira GB; Pagnano RG; Volpon JB; Annichino-Bizzacchi JM
J Pediatr Orthop; 1999; 19(1):84-7. PubMed ID: 9890294
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
6. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.
Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G
Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861
[TBL] [Abstract][Full Text] [Related]
7. [Incidence of thrombophilic factor V Leiden and prothrombin G20210A mutation in Perthes disease--a pilot study].
Schmitz A; Pförtner J; Protzel A; Harbrecht U
Z Orthop Ihre Grenzgeb; 2001; 139(2):143-6. PubMed ID: 11386104
[TBL] [Abstract][Full Text] [Related]
8. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease.
Glueck CJ; Glueck HI; Greenfield D; Freiberg R; Kahn A; Hamer T; Stroop D; Tracy T
Pediatr Res; 1994 Apr; 35(4 Pt 1):383-8. PubMed ID: 8047373
[TBL] [Abstract][Full Text] [Related]
9. Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
Cooley BC; Chen CY; Schmeling G
Thromb Res; 2007; 119(6):747-51. PubMed ID: 16793123
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
11. Gene mutations in 21 unrelated cases of phenotypic heterozygous protein C deficiency and thrombosis. Protein C Study Group.
Ireland H; Thompson E; Lane DA
Thromb Haemost; 1996 Dec; 76(6):867-73. PubMed ID: 8972002
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the FV:Q506 mutation in unselected oncology patients.
Otterson GA; Monahan BP; Harold N; Steinberg SM; Frame JN; Kaye FJ
Am J Med; 1996 Oct; 101(4):406-12. PubMed ID: 8873512
[TBL] [Abstract][Full Text] [Related]
13. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
[TBL] [Abstract][Full Text] [Related]
15. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
Herman M; Djelmis J; Troselj Z; Ivanisević M
Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
[TBL] [Abstract][Full Text] [Related]
16. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke.
Glueck CJ; Fontaine RN; Wang P
Thromb Haemost; 2001 Feb; 85(2):256-9. PubMed ID: 11246543
[TBL] [Abstract][Full Text] [Related]
17. [Multiple osteonecroses and venous thrombosis: one case of patient with a novel mutation of protein C (N102S) and heterozygous for FV Leiden].
Benbih M; de Maistre E; Lecompte T; Mainard D; Laprevote MC; Alhenc-Gelas M; Devignes J
Ann Biol Clin (Paris); 2008; 66(4):437-40. PubMed ID: 18725346
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
19. Age at onset-dependent presentations of premature hip osteoarthritis, avascular necrosis of the femoral head, or Legg-Calvé-Perthes disease in a single family, consequent upon a p.Gly1170Ser mutation of COL2A1.
Su P; Li R; Liu S; Zhou Y; Wang X; Patil N; Mow CS; Mason JC; Huang D; Wang Y
Arthritis Rheum; 2008 Jun; 58(6):1701-6. PubMed ID: 18512791
[TBL] [Abstract][Full Text] [Related]
20. Familial thrombophilia and the prothrombin 20210A mutation: association with increased thrombin generation and unusual thrombosis.
Eikelboom JW; Ivey L; Ivey J; Baker RI
Blood Coagul Fibrinolysis; 1999 Jan; 10(1):1-5. PubMed ID: 10070829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
